Top

05-07-2016 | Lung and thoracic tumors | Book chapter | Article

Lung Cancer Screening: Evidence, Recommendations, and Controversies

Authors: Robin Peters, MD, Matthijs Oudkerk, MD, PhD, Rozemarijn Vliegenthart, MD, PhD

Publisher: Springer International Publishing

Abstract

Lung cancer causes the most cancer-related deaths worldwide. The incidence of lung cancer increases with age, and the most important risk factor is smoking. Smoking prevention and cessation programs have decreased the number of lung cancer cases. The overall prognosis of lung cancer remains poor, despite advances in treatment. The purpose of lung cancer screening is detecting malignancy at an earlier and curable stage. The National Lung Screening Trial demonstrated that early detection of lung cancer with low-dose computed tomography (LDCT) decreases mortality compared with screening by chest radiography. In the United States, several organizations published guidelines, recommending implementation of lung cancer screening for high-risk patients. However, some important questions regarding LDCT screening have so far been unanswered. The awaited results of the European trials and pooling of data will be crucial in establishing recommendations regarding clinical implementation of lung cancer screening in asymptomatic high-risk persons. This review presents an overview of current evidence, recommendations, and controversies concerning lung cancer screening.

Aberle DR, DeMello S, Berg CD et al (2013) Results of two incidence screenings in the National Lung Screening Trial. N Engl J Med 369:920–931CrossRefPubMedPubMedCentral

American College of Radiology website. Guidance for ACR members on lung cancer screening with CT. www.acr.org. Published 24 June 2013. Accessed 4 Nov 2013.

American Lung Association (2012) Providing guidance on lung cancer screening to patients and physicians (internet). American Lung Association, Chigaco

Bach P, Kelly M, Tate R, McCrory DC (2003) Screening for lung cancer: a review of the literature. Chest 123(Suppl 1):72S–82SCrossRefPubMed

Baldwin DR, Duffy SW, Wald NK et al (2011) UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 66:308–313CrossRefPubMedPubMedCentral

Becker N, Motsch E, Gross ML et al (2012) Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol 138:1475–1486CrossRefPubMed

Black WC, Gareen IF, Soneji SS et al (2014) Cost-effectiveness of CT screening in the National Lung Cancer Screening Trial. N Eng J Med 371:19CrossRef

Buckens CF, van der Graaf Y, Verkooijen HM et al (2015) Osteoporosis markers on low-dose lung cancer screening chest computed tomography scans predict all-cause mortality. Eur Radiol 25(1):132–139CrossRefPubMed

Detterbeck FC, Mazzone PJ, Naidich DP et al (2013) Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(Suppl):e78S–e92SCrossRefPubMedPubMedCentral

Field JK, van Klaveren R, Pedersen JH et al (2013) European randomized lung cancer screening trials: post NLST. J Surg Oncol 108:280–286CrossRefPubMed

Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR et al (1991) Screening for lung cancer: a critique of the Mayo Lung Project. Cancer 67(4 Suppl):1155–1164CrossRefPubMed

Frost JK, Ball WC Jr, Levin ML et al (1984) Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 130(4):549–554PubMed

Henschke CI, McCauley DI, Yankelevitz DF et al (1999) Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 354:99–105CrossRefPubMed

Heuvelmans MA, Oudkerk M, de Bock GH et al (2013) Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Eur Radiol 23(7):1836–1845CrossRefPubMed

Horeweg N, van der Aalst CM, Thunnissen E et al (2013) Characteristics of lung cancers detected by computed tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med 187:848–854CrossRefPubMed

Horeweg N, van Rosmalen J, Heuvelmans MA et al (2014a) Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 15(12):1332–1341CrossRefPubMed

Horeweg N, Th Scholten E, de Jong PA et al (2014b) Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 15(12):1342–1350CrossRefPubMed

Humphrey LL, Teutsch S, Johnson M, U. S. Preventive Services Task Force (2004) Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med 140(9):740–753CrossRefPubMed

ICRP (1977) Recommendations of the ICRP. Ann ICRP 1:3

Infante M, Lutman FR, Cavuto S et al (2008) Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer 59:355–363CrossRefPubMed

Infante M, Cavuto S, Lutman FR et al (2009) A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 180:445–456CrossRefPubMed

Iribarren C (2000) Reexamining health effects of cigar smoking: fashionable, but may increase the risk of coronary heart disease. Eur Heart J 21:505–506CrossRefPubMed

Jacobs EJ, Thun MJ, Apicella LF (1999) Cigar smoking and death from coronary heart disease in a prospective study of US men. Arch Intern Med 159:2413–2418CrossRefPubMed

Jacobs PC, Mali WP, Grobbee DE, van der Graaf Y (2008) Prevalence of incidental findings in computed tomographic screening of the chest: a systematic review. J Comput Assist Tomogr 32(2):214–221CrossRefPubMed

Jacobs PC, Gondrie MJ, Mali WP et al (2011) Unrequested information from routine diagnostic chest CT predicts future cardiovascular events. Eur Radiol 21(8):1577–1585CrossRefPubMedPubMedCentral

Jacobs PC, Gondrie MJ, van der Graaf Y et al (2012) Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer. AJR Am J Roentgenol 198(3):505–511CrossRefPubMed

Jaklitsch MT, Jacobson FL, Austin JH et al (2012) The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 144:33–38CrossRefPubMed

Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed

Kaneko M, Eguchi K, Ohmatsu H et al (1996) Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 201:798–802CrossRefPubMed

Kucharczyk MJ, Menezes RJ, McGregor A et al (2011) Assessing the impact of incidental findings in a lung cancer screening study by using low-dose computed tomography. Can Assoc Radiol J 62:141–145CrossRefPubMed

Lopes Pegna A, Picozzi G, Mascalchi M et al (2009) Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low dose CT. Lung Cancer 64:34–40CrossRefPubMed

Marcus P, Bergstralh E, Fagerstrom R et al (2000) Lung cancer mortality in Mayo Lung Project: impact of extended follow up. J Natl Cancer Inst 92:1308–1316CrossRefPubMed

Mets OM, Buckens CF, Zanen P et al (2011) Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. JAMA 306(16):1775–1781CrossRefPubMed

Molina JR, Yang P, Adjei AA et al (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment and survivorship. Mayo Clin Proc 83(5):584–594CrossRefPubMedPubMedCentral

Moyer VA, U.S. Preventive Services Task Force (2014) Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160:330–338PubMed

Nair A, Hansell DM (2011) European and North American lung cancer screening experience and implications for pulmonary nodule management. Eur Radiol 21(12):2445–2454CrossRefPubMed

National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:35–409CrossRef

Oken MM, Hocking WG, Kvale PA et al (2011) Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 306:1865–1873CrossRefPubMed

Paoletti L, Jardin B, Carpenter MJ, Cummings KM, Silvestri GA (2012) Current status of tobacco policy and control. J Thorac Imaging 27:213–219CrossRefPubMedPubMedCentral

Pastorino U (2006) Early detection of lung cancer. Respiration 73:5–13CrossRefPubMed

Pastorino U, Rossi M, Rosato V et al (2012) Annual or biennial CT screening versus observation in heavy smokers: 5-years results of the MILD trial. Eur J Cancer Prev 21:308–315CrossRefPubMed

Patz EF Jr, Pinsky P, Gatsonic C et al (2014) Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 174(2):269–274CrossRefPubMedPubMedCentral

Pedersen JH, Ashraf H, Dirksen A et al (2009) The Danish randomized lung cancer CT screening trial: overall design and results of the prevalence round. J Thorac Oncol 4:608–614CrossRefPubMed

Richardson CM, Pointon KS, Manhire AR et al (2002) Percutaneous lung biopsies: a survey of UK practice based on 5444 biopsies. Br J Radiol 75(897):731–735CrossRefPubMed

Romme EA, Murchison JT, Phang KF et al (2012) Bone attenuation on routine chest CT correlates with bone mineral density on DXA in patients with COPD. J Bone Miner Res 27:2338–2343CrossRefPubMed

Saghir Z, Dirksen A, Ashraf H et al (2012) CT screening for lung cancer brings forward early disease. The randomized Danish lung cancer screening trial: status after five annual screening rounds with low-dose CT. Thorax 67:296–301CrossRefPubMed

Shaper AG, Wannamethee SG, Walker M (2003) Pipe and cigar smoking and major cardiovascular events, cancer incidence and all-cause mortality in middle-aged British men. Int J Epidemiol 32:802–808CrossRefPubMed

Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29CrossRefPubMed

Sverzellati N, Cademartiri F, Bravi F et al (2012) Relationship and prognostic value of modified coronary artery calcium score, FEV1 and emphysema in lung cancer screening population: the MILD trial. Radiology 262(2):460–467CrossRefPubMed

Van den Bergh KA, Essink-Bot ML, Borsboom GJ et al (2010) Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer 102:27–34CrossRefPubMed

Van der Aalst CM, van den Bergh KA, Willemsen MC et al (2010) Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax 65:711–718CrossRef

Van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K et al (2007) Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomized lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 120(4):868–874CrossRefPubMed

Van Klaveren RJ, Oudkerk M, Prokop M et al (2009) Management of lung nodules detected by volume CT scanning. N Engl J Med 361:2221–2229CrossRefPubMed

Wender R, Fontham ET, Barrera E Jr et al (2013) American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 63:107–117CrossRefPubMedPubMedCentral

Wood DE, Eapen GA, Ettinger DS et al (2012) Lung cancer screening. J Natl Compr Canc Netw 10(2):240–265PubMed

World Health Organization. Updated May 2014. www.who.int/mediacentre/factsheets/fs310/en/accessed march 10, 2016

Xu DM, Gietema H, de Koning H et al (2006) Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 54(2):177–184CrossRefPubMed

Zhao YR, Xie X, de Koning HJ, Mali WP, Vliegenthart R, Oudkerk M (2011) NELSON lung cancer screening study. Cancer Imaging 11:S79–S84CrossRefPubMedCentral

Medicine Matters Oncology

Abstract